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ABSTRACT
Purpose: To select relevant and feasible instruments for the revision of the Dutch clinical practice guide-
line for physical therapy in patients with stroke.
Methods: In this implementation study a comprehensive proposal for ICF categories and matching instru-
ments was developed, based on reliability and validity. Relevant instruments were then selected in a con-
sensus round by 11 knowledge brokers who were responsible for the implementation of the selected
instruments. The feasibility of the selected instruments was tested by 36 physical therapists at different
work settings within stroke services. Finally, instruments that were deemed relevant and feasible were
included in the revised guideline.
Results: A total of 28 instruments were recommended for inclusion in the revised guideline. Nineteen
instruments were retained from the previous guideline. Ten new instruments were tested in clinical prac-
tice, seven of which were found feasible. Two more instruments were added after critical appraisal of the
set of the measurement instruments.
Conclusions: The revised guideline contains 28 relevant and feasible instrument selected and tested in
clinical practice by physical therapists. Further education and implementation is needed to integrate
instruments in clinical practice. Further research is proposed for developing and implementing a core set
of measurement instruments to be used at fixed time points to establish data registries that allow for con-
tinuous improvement of rehabilitation for stroke patients.
 IMPLICATIONS FOR REHABILITATION
 The revised Dutch Stroke Physical Therapy Guideline recommends a total of 28 instruments, that are
relevant and feasible for clinical practice of physical therapist in the different settings of stroke
rehabilitation.
 The selection of instrument in daily practice should be part of the clinical reasoning process of PTs
and be tailored to individual patients’ needs and the degree of priority of the affected ICF category.
 Suggested education strategies for further integration of instruments in of the daily practice of PTs in
Stroke Rehabilitation are: ‘Training on the job’ and ‘peer assessment in clinical situations’.
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Reliable and valid clinical measurement instruments can be used
to guide stroke rehabilitation and can provide opportunities to
evaluate quality of care.[1–3] Valid assessments support evidence-
based practice since they may direct functional prognosis and
allow health professionals to establish realistic, attainable treat-
ment goals.[1,4–7] Clinical measurements also allow for monitor-
ing of change in patients within a treatment episode but also
within regional stroke services, and provides transparency across
stroke services.[1] These bedside assessments should be simple,
easy to use in daily practice and responsive to clinical change.
Physical therapists (PTs) have previously reported that meas-
urement instruments are not routinely used in daily practice and
that little information about patient recovery is transferred within
stroke services.[4] Multiple implementation barriers to the use of
measurement instruments in stroke rehabilitation have been iden-
tified, such as insufficient knowledge among PTs, low perceived
value of some instruments, and time investment to administer the
instrument.[4,5,8–12] However, the majority of PTs have shown an
increasingly positive attitude towards a systematic implementation
of clinical measurements for screening and monitoring as a part
of evidence-based practice.[11,13]
The first Dutch clinical practice guideline for physical therapy
for patients with stroke (CPGPTS) was published in 2004 and rec-
ommended 7 core measurement instruments that were required
and 18 additional optional instruments that are suggested for
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physical therapy in stroke patients.[14] During the ten years after
the launch of this first CPGPTS, there was a rapid increase in pub-
lished clinical trials, from 123 to 467. This rapid increase in avail-
able evidence required a revision of the CPGPTS.[15]
Subsequently, the question arose if the recommended measure-
ment instruments still covered the spectrum of ICF categories that
are affected by stroke and are relevant to physical therapy. Known
attempts are made to construct core sets in stroke with a focus
on psychometric properties and for research purposes.[16–20]
However, to improve the use of measurement instruments in clin-
ical practice, the abovementioned implementation barriers should
be taken into account when selecting instruments for the revised
guideline.[12,21] PTs had to perceive the instruments as relevant
to daily practice, and the instruments should be found feasible in
clinical practice, and preferably applicable in all phases and set-
tings of stroke rehabilitation.
Our study aimed to select relevant and feasible measurement
instruments in the context of the revision of the CPGPTS.[15,22]
Our first objective, described in part 1, was to evaluate the ICF cate-
gories and matching measurement instruments from the previous
CPGPTS, to identify missing ICF categories considered relevant to
physical therapy stroke rehabilitation, and to select measurement
instruments for the missing ICF categories. Our second objective,
described in part 2, was to assess the feasibility of these added
measurement instruments by implementing them in different phys-
ical therapy settings across the continuum of stroke care.
Methods
Study design
This pilot implementation study presents the selection process and
pilot testing of relevant and feasible measurement instruments
using the steps based on a model of systematic implementation
[23] (Figure 1). Implementation, also known as knowledge transla-
tion, takes place within a complex system of interactions between
researchers and users of new knowledge.[24] The interactive pro-
cess is underpinned by effective exchanges between researchers
who create new knowledge and those who use it. This implies a
systematic approach from establishing a proposal for implementa-
tion towards developing, testing and evaluating implementation
strategies.[23] In part 1 of our study (Step A and B) we describe
how relevant categories with accompanying instruments were
identified and selected in developing a proposal for implementa-
tion. In part 2 (Step C to G) we describe how implementation strat-
egies were developed and evaluated in a pilot implementation
study. Finally we conclude which measurement instruments were
recommended for inclusion in the revised CPGPTS. An instrument
Figure 1. Steps of the study, with a flowchart of the retained and rejected measurement instruments. n : number; MI: Motricity Index; 10MWT: 10-Meter Walk Test;
FMA: Fugl Meyer Assessment; 6MWT with RPE: Six-minute walk test combined with Rating of Perceived Exertion; TCT: Trunk Control Test; BBS: Berg Balance Scale; FAC:
Functional Ambulation Categories; TIS: trunk Impairment Scale; TUG: Timed Up and Go; FAT: Frenchay Arm Test; ARAT: Action Research Arm Test; NHPT: Nine Hole Peg
Test; BI: Barthel Index; NEADL: Nottingham Extended Activities of Daily Living Index; SSQOL: Stroke-specific Quality of Life questionnaire; NNM: Neutral-0-Method; MAS:
Modified Ashworth Scale; EmNSA: Erasmus Medical Center modification of the (revised) Nottingham Sensory Assessment; NPRS: Numeric Pain Rating Scale; FES: Falls
Efficacy Scale; NIHSS: National Institutes of Health Stroke Scale; FSS: Fatigue Severity Scale; HADS: Hospital Anxiety and Depression Scale; MoCA: Montreal Cognitive
Assessment; O-LCT: O-Letter Cancelation Test; CIRS: Cumulative Illness Rating Scale; MRS: Modified Ranking Scale; CSI: Caregiver Strain Index; SIS: Stroke Impact Scale;
SA-SIP30: Stroke-Adapted Sickness Impact Profile.
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was deemed clinical relevant when it provides a PT quantified
information considered useful for (1) diagnosis or functional prog-
nosis, (2) evaluation of functional status or (3) communication
between colleagues or with patients. An instrument was deemed
feasible by PTs when the time needed for administering was
acceptable, the use of the instrument was easy to interpret for the
patients and examiner, the license requirements were acceptable,
the instrument was sufficiently responsive for change, and barriers
could be settled in the pilot implementation.
Setting and study population
In part 1, 11 PTs working in stroke rehabilitation participated in
the process of selecting measurement instruments. These PTs
were fulfilling the role of knowledge brokers (KBs) in their own
setting and stroke service. A KB provides a link between research-
ers and end users by translating research evidence into local pol-
icy and practice.[25] KBs are early adopters in innovation and
skilled in motivating and facilitating colleagues to implement evi-
dence into clinical practice and local policy.
Our knowledge transfer program was built around the activities
of the KBs in a multifaceted tailored intervention where they
incorporate best practices into existing routines. The 11 KBs were
selected from the professional network of the guideline steering
group members based on criteria education, professional experi-
ence with stroke patients and based on motivation and skills to
perform implementation. The KBs were selected from different set-
tings within stroke services, reflecting the whole continuum of
stroke care, i.e., the hospital stroke unit (n¼ 3), rehabilitation cen-
ter inpatient as well as outpatient (n¼ 2), nursing home (n¼ 4),
and community-based physical therapy practice (n¼ 2).
For part 2 each of the 11 KBs selected at least two fellow PTs
within their stroke service, that represent their work setting and
each judged the feasibility of the selected candidate measurement
instruments.
Data collection
Part 1: Identification and selection of relevant ICF categories and
matching measurement instruments
Step A: Identification. A comprehensive proposal was devel-
oped, consisting of the categories and measurement instruments
that had already been recommended in the Dutch 2004 CPGPTS,
[14] supplemented with candidates ICF categories and corre-
sponding instruments relevant to physical therapy for patients
after stroke. The proposal was completed using the clinical experi-
ence of the steering group with stroke rehabilitation. The new cat-
egories and instruments were identified based on (non-
systematic) literature search for studies aimed at measurement
properties of measurement instruments in stroke rehabilitation.
Measurement instruments were selected when (1) there was evi-
dence for their measurement properties (i.e. reliability and valid-
ity); (2) they were deemed relevant for physical therapy
management in stroke rehabilitation, and (3) they were deemed
applicable in daily practice with little resource use.[26] The com-
prehensive proposal was discussed in the project team using the
three selection criteria until consensus was reached.
Step B: Selection. The proposal was discussed in a consensus
meeting of the KBs, chaired by the project staff (JV and GK), to
come to agreement on the clinical relevance of the ICF categories
and matching measurement instruments for physical therapy.
Consensus on relevance was reached with plurality decisions
derived from social decision schemes. Overlap between instru-
ments was checked for, and clinical applicability was discussed.
If more than one measurement instrument was considered rele-
vant for a particular ICF category, the literature was reviewed to
search for decisive information on measurement properties. ICF
categories and matching measurement instruments were selected
for feasibility testing after full consensus among all KBs had been
achieved.
Part 2: Developing implementation strategies and evaluating
the implementation of the selected measurement instruments
Step C: Analysis of target group and setting. An online survey
among the participating KBs and their fellow PTs was conducted
to identify the setting and the therapist characteristics.
Step D: Selection of implementation strategies. To achieve bet-
ter outcomes [21] we applied a mix of implementation strategies
tailored to the target group and context. First, we organized a
plenary educational meeting on measurement instruments for the
KBs and their fellow PTs. Second, we provided a lecture on clinical
decision-making and the application of measurement instruments
for the KBs followed by a knowledge test and an interactive dis-
cussion. Third, we facilitated local implementation strategies at
organizational level using feedback and reminders. These specific
activities of a KB were not standardized because they should be
responsive to the needs of the stakeholders.[27,28] Finally, educa-
tional material was distributed to all participants.
We used the following benchmarks to assess successful com-
pletion of step D: (D1) 90% of the KBs attended the kickoff day
on plenary implementation strategies or arranged for a substitute
to attend; (D2) 90% of the KBs were accompanied by at least
one colleague at the kickoff day. The benchmarks were developed
by NMO and JMV and discussed in the project team to reach con-
sensus. We also used this method for selecting benchmarks in
steps E and F. The success of local implementation strategies are
evaluated in step E. Achievement of the benchmarks was manda-
tory to proceed to the next step in implementation.
Step E: Delivery of implementation strategies. A kickoff day
was delivered for all KBs and their fellow PTs, the second plenary
meeting after step D. During this day each of the KBs presented
one of the candidate measurement instruments, including its pur-
pose, use (including a video instruction), measurement properties,
interpretation of the scores, and a clinical example, followed by a
plenary discussion. Secondly, a lecture was given for the KBs
about clinical decision-making and the application of measure-
ment instruments. It was illustrated by a case study, after which a
set of open-ended questions was presented on the use and inter-
pretation of measurement instruments, which KBs had to answer
individually. Thirdly local implementation strategies were carried
out by the KBs each in their setting and stroke service for five
months. After this period the implementation of the instruments
was assessed. Each candidate instrument was administered in all
settings to assess the applicability of the instruments across the
whole stroke care continuum. Every month, the KBs reported to
the project staff on the progress of the project, including any
problems. The KBs were instructed to contact the project staff if
any questions or problems arose. Fourthly, educational material
was distributed. All participants received a handbook and a CD
providing both written and digital versions of the measurement
instruments.
Benchmarks to assess successful completion of step E were
defined as:
(E1) 90% of the KBs administered the instruments together
with their fellow PTs to at least 10 patients suffering from stroke,
according to a standardized evaluation form; (E2) 90% of the
KBs, together with their fellow PTs, identified the perceived bar-
riers and facilitators for each instrument; (E3) 90% of the KBs
wrote a justification for90% of the cases where a particular
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measurement instrument had not been used for a particular
patient.
Step F: Evaluation of the implementation strategy. The feasibil-
ity of the proposed instruments was evaluated using a standar-
dized survey in which the following aspects were assessed: the
time needed for administering, for which type of patients the
instrument was relevant, the clarity of the instrument for patients,
the license requirements, and facilitators and barriers for use. This
survey was completed by each KB together with their fellow PTs.
The survey was developed by designing a draft questionnaire that
was submitted to the steering group for the CPGPTS for several
review rounds. The survey results were discussed with the KBs
during an evaluation meeting after completion of the five-month
implementation period. For each measurement instrument infor-
mation was collected about (1) the number of patients tested and
the number of patients in each post-stroke phase, (2) the purpose
of administering the instrument (e.g. diagnostic, prognostic, evalu-
ative), (3) the implementation strategies used locally and the time
investment for each measurement, (4) reasons for not applying
the measurement instrument, (5) barriers and facilitators, (6)
requirements for measuring, and (7) recommendations on whether
the instrument should be included in the revised CPGPTS .
Benchmarks for step F were: (F1) 90% of the KBs attended a
meeting to evaluate the measurement instruments or arranged
for a substitute to attend; (F2) 90% of the KBs wrote an evalu-
ation document for each instrument including barriers and facilita-
tors for implementation, and (F3) 90% of the KBs provided a
recommendation on whether or not the instrument should be
included in the updated CPGPTS.
A candidate measurement instrument was deemed feasible
and included in the updated CPGPTS if60% of the KBs initially
recommended it in their evaluation (benchmark F4), and if full
consensus (100%) was reached in a final discussion.
Step G: Critical appraisal of the final set. The final set of meas-
urement instruments was critically appraised for completeness.
Instruments were only added if supported by all KBs. Relevant
and feasible measurement instruments were selected for inclusion
in the revised CPGPTS.
Data processing and analysis
Feasibility reports and recommendations for measurement instru-
ments were examined by entering data in an Excel database
(Microsoft, Redmond, WA). Descriptive statistics were used to ana-
lyze participants, settings, patient characteristics and all
benchmarks.
Results
Part 1: Identification and selection of relevant ICF categories and
matching measurement instruments
In step A the targeted literature search resulted in a compre-
hensive proposal consisting of 26 ICF categories and 40 matching
measurement instruments identified as relevant for physical ther-
apy management.[17–20,29–31] Twenty-four of these 40 instru-
ments had already been recommended in the 2004 CPGPTS,[14]
whereas 16 instruments were newly identified as candidates for
the revised CPGPTS (Figure 1).
In Step B, five instruments from the 2004 CPGPTS [14] were
rejected. The Rivermead Mobility Index (RMI), Timed Balance Test
(TBT) and Frenchay Activities Index (FAI) were redundant to the
Timed Up and Go (TUG), Trunk Control Test (TCT) and Berg
Balance Scale (BBS) and the Nottingham Extended ADL Index
(NEADL), respectively. The volume measurement with a water tank
(VWT) to measure edema was not being used in daily practice,
due to low perceived practice relevance and unknown measure-
ment properties. The cranial nerve examination (CNE) was found
to be less suitable for measuring neurological function than the
National Institutes of Health Stroke Scale (NIHSS), which has excel-
lent predictive properties.[32] Six of the new instruments were
rejected. The Tardieu scale was rejected because its measurement
properties were not found to be superior to those of the Modified
Ashworth Scale (MAS), which was already listed in the previous
guideline.[33,34] The Steep Ramp Test (SRT) was rejected due to
its unknown safety and validity in the stroke population, despite
its potential eligibility for testing maximum short-time exercise
capacity.[35] PTs were hesitant about using this high-intensity test
due to the risk of complications while performing the test, and
the 6-MWTþ RPE was retained for measuring exercise tolerance as
an adjacent category. Two instruments for measuring perceived
limitation of functioning, Patient Specific Complaints (PSK) and
Goal Attainment Scaling (GAS) were both rejected because their
measurement properties for the stroke population are unclear.[36]
The Stroke Adapted Sickness Impact Profile (SA-SIP30) and Stroke
Impact Scale (SIS) were assumed to be inferior to the Stroke
Specific Quality of Life (SSQOL), because they are lengthy and less
easy to administer in daily practice.[37]
In the end, 24 ICF categories were selected in full consensus,
with 19 measurement instruments retained from 2004 and 10
new instruments judged to be clinically relevant for physical ther-
apy after stroke.
Part 2: Developing implementation strategies and evaluating
the implementation of the selected measurement instruments
Table 1 shows the characteristics of the 36 participating PTs,
11 of whom were KBs and 25 were colleagues of the KBs (Step C).
Most participants worked at nursing homes (KBs 42%, PTs 42%),
followed by hospitals (KBs 25% and PTs 32%), community-based
physical therapy practices (KBs 16%, PTs 16%) and rehabilitation
centers (KBs 17% and PTs 10%).
Step D, E and F were successfully completed for all of the eight
stated benchmarks.
Table 2 shows the implementation strategies selected and
applied by the KBs.
The evaluation reports of the 10 additional measurement
instruments that were tested are presented in Table 3. Seven
measurement instruments were included in the final set of instru-
ments based on the final consensus round: measuring exercise
tolerance with the Six-Minute Walking Test combined with Borg
rating of perceived exertion (6MWTþ RPE), fatigue with the
Fatigue Severity Scale (FSS), anxiety and depression with the
Hospital Anxiety and Depression Scale (HADS), cognitive function
with the Montreal Cognitive Assessment (MoCA), neurological
functions and severity of stroke with the National Institutes of
Health Stroke Scale (NIHSS), quality of life with the Stroke-specific
Quality of life questionnaire (SSQOL), and caregiver strain with the
Caregiver Strain Index (CSI).
Three instruments were not recommended; the Motor Activity
Log (MAL), Short Questionnaire to Assess Health-Enhancing
Physical Activity (SQUASH) and the Step Count (SC). The MAL and
SQUASH were rejected due to instrument-level issues: both instru-
ments had unclear scoring options. In addition, for the MAL the
PTs perceived little relevance of the activities described in the
MAL, reference values were lacking and also less suitable because
of its reproducibility and longitudinal construct validity.[37]
Furthermore, the SC lacks standardized instructions and reference
values for the patients with stroke.
In step G, the KBs concluded that two relevant categories for
screening and classifying patients at baseline were missing:
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neglect and multi-morbidity. Since the KBs were familiar with two
matching tests in daily practice, they recommended adding the
O-Letter Cancelation Test (O-LCT) and the Cumulative Illness
Rating Scale (CIRS) for these categories, respectively.
Table 4 lists this final set, consisting of 22 ICF categories with
28 instruments, and indicates their relevance for each phase.
Discussion
Principal findings
To our knowledge, this is the first study aimed to describe a strat-
egy for selecting measurement instruments for a clinical practice
guideline for physical therapy from an implementation perspec-
tive. The participation of professionals in the selection of instru-
ments and the thorough evaluation of their feasibility in clinical
practice is unique and should enhance the implementation of
measurement instruments in clinical practice. Twenty-eight instru-
ments were recommended for inclusion in the revised Dutch
CPGPTS. This large number of instruments suggested for physical
therapy in patient suffering from stroke reflects the variability and
complexity of the effects of a stroke on a patient’s condition and
also reflects the variation across the different post-stroke phases.
[1] In our opinion, the next challenge is to develop and imple-
ment a core set of measurement instruments to be administered
at fixed time points post-stroke to monitor changes in patients
treated, irrespective of the location of admission within the stroke
services.[1] Data registries should be established for the purpose
of quality-of-care assessments.
Strengths and limitations of our study
The main strength of our study lies in the participation of profes-
sionals. Knowledge translation implies co-creation between
researchers and knowledge users [24] and in this study clinical
experience from different settings of stroke services was engaged
during the selection process. Input on perceived relevance and
clinical feasibility in the selection process is expected to enhance
successful implementation of the new measurement instruments
in daily practice. Another strength of our study was the thorough
evaluation of new instruments in terms of time investment for
their administration, for which type of patients the instrument
was relevant, clarity of the questionnaires for patients, license
requirements, and any facilitators and barriers identified.
Feasibility of the 10 new instruments was assessed on the basis of
a mean number of 100 patients tested for each instrument. We
added two instruments (i.e. O-LCT, CIRS) in the final stage of the
study, after the pilot implementation of the candidates for new
instruments. Neither the O-LCT nor the CIRS were included in the
initial selection of measurement instruments, which meant we
deviated from our methodology based on the model by Grol.[23]
In this final stage we concluded that consensus on clinical rele-
vance, combined with the KBs’ experience regarding feasibility,
provided sufficient arguments for adding these two measures to
the final set. We acknowledge that they were not as thoroughly
tested on feasibility as the other new instruments.
The results of this study should be interpreted cautiously as
regards the measurement properties reflecting the methodological
quality of the instruments. Although there is an overlap with
instruments selected in studies focusing on measurement proper-
ties,[16–20] most instruments have been developed for research
purposes. They are used to identify differences at population level,
whereas in clinical practice measurement instruments are used for
individual patients. As a consequence, measures such as the small-
est detectable change cannot be directly transferred to the indi-
vidual level. Furthermore, measurement properties relevant to
individual patients, such as the minimal clinically important
Table 2. Local implementation strategies selected and applied by the 11 KBs.
Selected implementation strategy Applied; n (%)
In-service training of colleagues 9 (81.8)
Forms, test materials and rooms made available 11 (100)
Forms are available in patient record 2 (18.2)
Feedback during PT meeting 8 (72.2)
Peer feedback or case discussion 2 (18.2)
Standardized inclusion in referral letter 1 (9.1)
Reminder by E-mail or telephone 6 (54.5)
Other
Update on whiteboard 3 (27.3)
Coaching 1 (9.1)
Supervision 2 (18.2)
Discussion of barriers 1 (9.1)
Test rounds with colleagues 1 (9.1)
n: number; %: percentage; PT: physical therapist.
Table 1. Characteristics of participants and settings, divided into knowledge brokers (KBs) and fellow physical therapists.
KB Fellow PT
Sex, N (%) Female 6 (54.5) 21 (84.0)
Age in years, mean (SD)a 40.4 (9.7) 40.9 (11.9)
Years employed as PT, mean (SD)b 18.4 (11.1) 17.8 (11.4)
Professional education, N (%) Bachelor’s degree in PT 11 (100) 25 (100)
Master of Science 1 (9.0) 0 (0)
Professional Master’s degree 0 (0) 1 (4.0)
Additional stroke coursesc Neuro Developmental Treatment (NDT) 5 (31.3) 11 (35.5)
Neurorehabilitation 7 (43.8) 10 (32.3)
Other 3 (18.8) 2 (6.5)
None 1 (6.3) 8 (25.8)
Work setting within stroke services, N (%) Hospital 3 (25.0) 10 (32.3)
Rehabilitation center 2 (16.7) 3 (9.7)
Nursing home (stroke unit, long-term care, day care) 5 (41.7) 13 (41.9)
Community-based PT 2 (16.7) 5 (16.1)
Hours per week treating patients with stroke, mean (SD)d 16.8 (11.2) 14.9 (9.7)
Missing values for KBs are indicated by superscripts: a3 missing, b2 missing, c1 missing and d2 missing.
KB: Knowledge broker; PT: physical therapist; n: number; SD: standard deviation; %: percentage.
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CSI 54 (6/37/8/3) EP/LP/CP D/E 5–10 Acceptable time invest-
ment (4)
Easy to administer (2)
Cutoff available (2)
Often not applicable in
AP (4)
Caregiver unknown (2)




Presence of a caregiver





Time window of 1 week
difficult to achieve in
AP (6)
Aphasia (2)
NIHSS 146 (22/101/2/12) AP/EP (<1 week
post stroke)







Applicable in all post-
stroke phases (2)
Aphasia (4)
Parts are used by differ-





from severe stroke (2)









No cutoff available (3)
Unclear and complex
scoring categories (3)
Not applicable in AP/<7
days (3)




MoCA 128 (62/26/16/20) AP/EP/LP/CP S 18–43 None specified High time investment (4)
Presence of interdiscip-
linary team (2)






MAL 56 (5/36/8/8) EP/LP/CP D/E/O; helpful
in goal
setting
20–30 Low financial investment
(2)




High time investment (2)
Some hand function
required















SC 23 (0/12/3/8) EP/LP Not specified 4–21 Motivates patient (3) None of the patients








Absence of low consciousness level, severe aphasia, language barriers or severe cognitive dysfunction.Training is available and can be followed up.
PT: Physical Therapist; AP: Acute phase (0–24 h); EP: Early phase (24 h–3 months); LP: Late phase (3–6 months); CP: Chronic Phase (>6 months); D: diagnostic; E:
evaluative; P: prognostic; S: screening; O: Other; FAC: Functional Ambulation Categories; 6MWT: Six-Minute Walk Test combined with Rating of Perceived Exertion;
FSS: Fatigue Severity Scale; HADS: Hospital Anxiety and Depression scale; MoCA: Montreal Cognitive Assessment; NIHSS: National Institutes of Health Stroke Scale;
MAL: Motor Activity Log; SQUASH: Short Questionnaire to Assess Health-enhancing Physical Activity; SC: Step Count measurement; SSQOL: Stroke-specific Quality of
Life questionnaire; CSI: Caregiver Strain Index.
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difference, are often unknown or based on one or few studies,
derived from a highly selected patient selection. This problem has
also been discussed by Salter et al.[19] They recommended several
instruments for use in clinical practice, and also acknowledged
that the diversity of contents and measurement properties of
available measures mean that PTs should carefully examine the
nature and scope of the instrument used in reporting the strength
of evidence for improved functional outcome of stroke rehabilita-
tion.[18]
Implications for clinical practice
The use of the instruments should be tailored to individual
patients’ needs, given the large number of instruments. The iden-
tified needs of individual patients, the degree of priority of the
affected ICF category and recommendations in the guideline
should guide the selection of measurement instruments and be
part of the clinical and shared decision making in the diagnostic
phase. In order to incorporate targeted use of measurement
instruments in clinical practice, professionals at stroke services
must be trained in using the measurement instruments as recom-
mended in the revised CPGPTS. A strategy to enhance adherence
of PTs in using measurement instruments, could be training on
the job and peer assessment in clinical situations. In peer assess-
ment professionals evaluate or are being evaluated by their peers
and provide each other with performance feedback that might
trigger reflection, and uncover areas of clinical performance that
need improvement.[38]
Similar to our pilot implementation study, further implementa-
tion should be conducted in a systematic approach informed by
theories and a comprehensive model for implementation. In add-
ition, it is highly recommended for PTs to follow a post-bachelor
course in neurorehabilitation, in which the application and clinical
decision making based on measurement instruments is one of the
central themes.
The new categories of neurological functions (stroke severity),
fatigue, anxiety and depression, cognitive functions, quality of life,
caregiver strain, neglect and multi-morbidity are not limited to
the physical therapy domains but cover a broader interdisciplinary
range.[2,14,17] Furthermore, the evaluation of these categories
and matching instruments revealed that their relevance varies in
different settings. For instance, a PT in primary care often does
not work in a stroke team, and plays an important role in identify-
ing patient problems like cognitive symptoms. The use of the
MoCa or CSI for example is helpful in identifying and reporting
findings to the referring physician, who can then undertake fur-
ther steps if necessary. On the other hand, if a PT works in a
stroke unit where an occupational therapist and neuropsycholo-
gist are available, there is less need for the PT to use the MoCa.
This underlines the relevance of a phase-specific set. In order to
facilitate this process, the CPGPTS indicates the value of the meas-
urement instruments for each post-stroke phase, by stating the
relevant phases for each instrument (Table 4).
Implications for future research
The categories of exercise tolerance, physical activity and per-
ceived limitation of functioning are considered highly relevant for
physical therapy practice, but do not have a prominent place in
the recommendations in the guideline, since valid and safe instru-
ments for the stroke population were found to be lacking. Our
participating PTs expressed the need for instruments that add
valid and reliable information on these categories. Furthermore,
the use of patient-reported outcome measures (PROMs) could be
investigated for the stroke population. PROMs measure health
gains reported by patients and may present a method to obtain
more information on long-term outcomes in stroke.[39] However,
this raises the question which PROMs are reliable, valid and
responsive enough to detect clinically meaningful changes in
health or functional status, and what time frame for data collec-
tion is appropriate for stroke patients.[39] In conclusion, we can
say that future research on psychometric properties of measure-
ment instruments in stroke population is warranted.
In our opinion, the next step at national level should be sys-
tematic evaluation of further implementation of the guideline.
Moreover, on an international level it is important to establish a
think tank that focusses on the development and implementation
Table 4. The set of relevant, applicable and feasible measurement instruments
covering aspects of stroke relevant for physical therapy for the revised CPGPTS.
AP EP LP CP
GAIT-RELATED MI LE    
Body functions 10MLT    
FMA LE    
6MWT with RPE    
GAIT-RELATED TCT    
Activities BBS    
FAC    
TIS    
TUG    
HAND AND ARM USE MI UE    
Body functions FMA UE    
HAND AND ARM FAT    
Activities ARAT    
NHPT    
BASIC ACITIVITIES OF DAILY LIVING BI    




OTHER NNM    
Body functions MAS    
EmNSA    
NPRS    
FES    
NIHSS  
FSS  
HADS   
MoCA    

O-CLT    
CIRS    
OTHER Activities MRS    

External factors CSI   
Shown in bold are the basic instruments retained from the 2004 guideline, and
in italics the new instruments.May be obtained from other discipline in multidisciplinary team.
AP: Acute phase (0–24 h); EP: Early phase (24 h–3 months); LP: Late phase (3–6
months); CP: Chronic Phase (>6 months); UE: upper extremity; LE: Lower
extremity; MI: Motricity Index; 10MWT: 10-Meter Walk Test; FMA: Fugl Meyer
Assessment; 6MWT with RPE: Six-minute walk test combined with Rating of
Perceived Exertion; TCT: Trunk Control Test; BBS: Berg Balance Scale; FAC:
Functional Ambulation Categories; TIS: trunk Impairment Scale; TUG: Timed up
and Go; FAT: Frenchay Arm Test; ARAT: Action Research Arm Test; NHPT: Nine
Hole Peg Test; BI: Barthel Index; NEADL: Nottingham Extended Activities of Daily
Living Index; SSQOL: Stroke-specific Quality of Life questionnaire; NNM: Neutral-
0-Method; MAS: Modified Ashworth Scale; EmNSA: Erasmus Medical Center
modification of the (revised) Nottingham Sensory Assessment; NPRS: Numeric
Pain Rating Scale; FES: Falls Efficacy Scale; NIHSS: National Institutes of Health
Stroke Scale; FSS: Fatigue Severity Scale; HADS: Hospital Anxiety and Depression
Scale; MoCA: Montreal Cognitive Assessment; O-LCT: O-Letter Cancelation Test;
CIRS: Cumulative Illness Rating Scale; MRS: Modified Ranking Scale; CSI:
Caregiver Strain Index.
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of a core set of measures of motor outcome post, that may be fol-
lowed by a core set cognitive outcomes. Preferably, these meas-
urements along the continuum of care as provided in different
settings should enable clinical data registration for the purpose of
quality-of-care assessments. To reach this goal, consensus should
first be achieved on a set that (1) includes basic outcome meas-
ures to monitor basic ICF constructs, (2) is able to cope with the
time-dependent dynamics of spontaneous neurological recovery
post-stroke irrespective of post-stroke phase, and (3) is easy for
use and interpretation in daily practice. In the literature there are
known attempts to implement standardized assessment sets, and
depending on the aim they vary from 6–9 included instruments
on motor domains.[2,17,31] However, these sets all seem rather
rigid, while flexibility to choose additional measurement instru-
ments is needed to focus on the identified needs of an individual
patient and on the priority of the affected category. Recently, an
international initiative has been planned by means of developing
an international consensus meeting for rehabilitation and recovery
research on measurement.[40] This aim of this first Stroke
Recovery and Rehabilitation Roundtable with over 60 experts is to
achieve consensus in four priority areas, i.e., preclinical recovery
research; biomarkers of recovery; intervention development, moni-
toring and reporting and measurement in clinical trials. For meas-
urement in clinical trials, important achievements would be to
standardize definitions for common terms (e.g. recovery), time-
points of measurement, and distinguish between difierent types
of outcomes following ICF.[40] After development, a complex
implementation process lies ahead. Successful implementation
requires paying attention to (1) consulting PTs with expertise on
the domain of stroke in the development of the core set, (2) the
level of knowledge and skill level of PTs regarding the chosen
instruments, and (3) organizational and financial prerequisites for
the construction of a database for long-term registration.
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